Wireless Device Provides Comprehensive Clinical Picture, Improves Patient-Physician Communications
KING OF PRUSSIA, Pa., Aug. 25 /PRNewswire/ -- Hemophilia A patients who use Helixate(R) FS, Antihemophilic Factor (Recombinant), and their treatment providers are now tracking treatment progress in real time, thanks to the HeliTraxSM System, a state-of-the-art wireless Internet-based data management system recently introduced by CSL Behring. The system allows for a comprehensive view of a patient's progress, with young patients relaying information about bleeding events and their use of Helixate FS to their hemophilia treatment center via the handheld device between office visits. The HeliTrax System, used in conjunction with Helixate FS treatment, is designed to improve patient-physician communications and therapy management.
"HeliTrax provides clinicians with the rapid, comprehensive clinical view they need to make assessments about treatment, it eliminates paperwork and helps to streamline patient data management," says Jill Leone, RN, CCRP, a hematology nurse who helped develop the system. "For young patients, HeliTrax helps them keep in touch with their therapy and motivates them to stay on track."
Physicians monitoring hemophilia A patients previously relied on paper
forms filled out by the patients or their caregivers, which did not always
provide necessary clinical information in a timely, clear and concise way.
HeliTrax not only tracks a patient's therapy as it happens -- including
medication usage and inventory -- but allows the hemophilia treatment
center to generate a one-page, easy-to-read, full-color clinical report of
the patient's progress. These private, secure reports, which help reduce
documentation and transcription errors, are compliant with both the Joint
Commission on Accreditation of Healthcare Organizations (JCAHO) and the
Health Insurance Portability and Accountability Act (HIPAA). Additionally,
the system is backed
|SOURCE CSL Behring|
Copyright©2008 PR Newswire.
All rights reserved